Literature DB >> 15744336

Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide.

A Dogan, L S P Ngu, S H Ng, P L Cervi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15744336     DOI： 10.1038/sj.leu.2403710

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?

Authors:  Karen L Grogg; Ayoma D Attygalle; William R Macon; Ellen D Remstein; Paul J Kurtin; Ahmet Dogan
Journal:  Blood       Date:  2005-08-15       Impact factor: 22.113

2.  Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk.

Authors:  Mariko Witalis; Jinsam Chang; Ming-Chao Zhong; Yasser Bouklouch; Vincent Panneton; Joanna Li; Thorsten Buch; Seok Jin Kim; Won Seog Kim; Young Hyeh Ko; André Veillette; Woong-Kyung Suh
Journal:  Blood Adv       Date:  2020-03-10

Review 3.  New molecular insights into peripheral T cell lymphomas.

Authors:  Stefano A Pileri; Pier Paolo Piccaluga
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

Review 4.  Molecular genetics of peripheral T-cell lymphomas.

Authors:  Pier Paolo Piccaluga; Valentina Tabanelli; Stefano A Pileri
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

5.  Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.

Authors:  Michael Medinger; Natalie Fischer; Alexandar Tzankov
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

Review 6.  The role of angiogenesis in human non-Hodgkin lymphomas.

Authors:  Domenico Ribatti; Beatrice Nico; Girolamo Ranieri; Giorgina Specchia; Angelo Vacca
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

7.  Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non-Hodgkin's lymphoma: A prospective study of 46 cases.

Authors:  Hongyang Wu; Chenchen Zhao; Kangsheng Gu; Yang Jiao; Jiqing Hao; Guoping Sun
Journal:  Mol Clin Oncol       Date:  2014-06-06

8.  An update on the management of peripheral T-cell lymphoma and emerging treatment options.

Authors:  Adrienne A Phillips; Colette Owens; Sangmin Lee; Govind Bhagat
Journal:  J Blood Med       Date:  2011-09-12

9.  Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.

Authors:  Yawen Wang; Mingzhi Zhang; Wei Song; Qingqing Cai; Liling Zhang; Xiuhua Sun; Liqun Zou; Huilai Zhang; Lili Wang; Hongwei Xue
Journal:  Am J Hematol       Date:  2022-03-11       Impact factor: 13.265

10.  Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin.

Authors:  Masashi Ohe; Satoshi Hashino
Journal:  Blood Res       Date:  2016-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.